Article
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.
Nature medicine - 24 Jul 2011
Best Timothy, Li Dalin, Skol Andrew D, Kirchhoff Tomas, Jackson Sarah A, Yasui Yutaka, Bhatia Smita, Strong Louise C, Domchek Susan M, Nathanson Katherine L, Olopade Olufunmilayo I, Huang R Stephanie, Mack Thomas M, Conti David V, Offit Kenneth, Cozen Wendy, Robison Leslie L, Onel Kenan
Abstract excerpt
Survivors of pediatric Hodgkin's lymphoma are at risk for radiation therapy-induced second malignant neoplasms (SMNs). We identified two variants at chromosome 6q21 associated with SMNs in survivors of Hodgkin's lymphoma treated with radiation therapy as children but not as adults. The variants comprise a risk locus associated with decreased basal expression of PRDM1 (encoding PR domain containing 1, with ZNF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
